[Study on the medium- and long-term adverse effects of a new anti-inflammatory agent: difenamide, on the stomach].
D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005756:Gastritis / Q000139:chemically induced; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects; D007592:Joint Diseases / Q000188:drug therapy; D010653:Phenylbutazone / Q000009:adverse effects; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use; D013270:Stomach / Q000187:drug effects*; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D001713:Biphenyl Compounds; D011725:Pyridines; D010653:Phenylbutazone; D007213:Indomethacin
Indagine sulla gastrolesività a medio e lungo termine di un nuovo farmaco antiflogistico: la difenamide.